Time to Response and Overall Survival in Patients with Midh1 Relapsed/Refractory Acute Myeloid Leukemia Treated with Olutasidenib
Blood(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined